---
title: "I need to design a meta-analysis. Guide me: 1) Develop specific research question"
description: "AI model comparison: I need to design a meta-analysis. Guide me: 1) Develop specific research question..."
date: 2025-10-15
category: comparison
layout: Clean
tags:
  - ChatGPT
  - Gemini
  - AI Comparison
author: SNEOS Community
head:
  - - meta
    - name: description
      content: "AI model comparison: I need to design a meta-analysis. Guide me: 1) Develop specific research question..."
---

<ChatComparison
  title="I need to design a meta-analysis. Guide me: 1) Develop specific research question"
  prompt="I need to design a meta-analysis. Guide me: 1) Develop specific research question"
  :responses='{"ChatGPT": "Designing a meta-analysis starts with formulating a clear and precise research question. Here are steps and considerations to help you develop a specific research question:\n\n### Step 1: Identify the Topic Area\nThink about the broad area of interest related to your field. What\u2019s the key issue or phenomenon you want to explore through the meta-analysis? \n\n**Considerations:**\n- What area has substantial research gaps?\n- Is there conflicting evidence in existing studies?\n- Are you looking to evaluate the effectiveness of a specific intervention, treatment, or exposure?\n\n### Step 2: Formulate the Research Question\nYour research question should be specific, measurable, and relevant. Using the PICO format (Population, Intervention, Comparison, Outcome) can be helpful. \n\n**Example Structure:**\n1. **Population**: Who are you studying (age group, disease, condition)?\n2. **Intervention**: What intervention or exposure are you interested in?\n3. **Comparison**: Are you comparing with another intervention, treatment, or a placebo?\n4. **Outcome**: What outcomes are you measuring (effectiveness, side effects, etc.)?\n\n### Example Research Questions\n1. **Health Psychology**: \u0022In adults with chronic anxiety (Population), how does cognitive-behavioral therapy (Intervention) compared to medication (Comparison) affect anxiety levels (Outcome)?\u0022\n  \n2. **Education**: \u0022What is the impact of mindfulness-based interventions (Intervention) on academic performance (Outcome) in high school students (Population) compared to traditional stress-reduction strategies (Comparison)?\u0022\n\n3. **Public Health**: \u0022What is the effectiveness of various vaccination strategies (Intervention) on reducing the incidence of influenza (Outcome) among older adults (Population) compared to no intervention (Comparison)?\u0022\n\n### Step 3: Refine the Question\nOnce you have a draft of your research question:\n- Ensure it\u2019s specific enough to guide your search for studies but broad enough to yield enough data.\n- Consider how you will define your terms.\n- Think about how you will assess the quality of the studies you include.\n\n### Final Example Research Question\nAfter refining, you might end up with a question like: \u0022Among adults aged 50 and older, how effective are lifestyle interventions (i.e., diet, exercise) compared to standard care in reducing the incidence of type 2 diabetes?\u0022\n\n### Conclusion\nYour research question should ultimately reflect your interests and the gaps in existing literature. Once your question is clearly defined, you can move on to the next steps in your meta-analysis design, such as defining inclusion and exclusion criteria, conducting a literature search, and planning for data extraction and analysis.", "Gemini": "Designing a meta-analysis starts with a crystal-clear, focused research question. This question will dictate your entire process: your search strategy, inclusion/exclusion criteria, data extraction, and statistical analysis.\n\nLet\u0027s break down how to develop a specific research question for a meta-analysis.\n\n---\n\n## 1) Develop a Specific Research Question\n\nThe foundation of any good research, especially a meta-analysis, is a well-defined question. For meta-analysis, this question needs to be particularly precise, as you\u0027ll be synthesizing quantitative data from multiple studies.\n\n**Key Principle:** Use a framework like **PICO** (for interventions), **PECO** (for exposures), or **PICOS** (adding Study Design) to structure your thinking.\n\n### The PICO/PECO/PICOS Framework\n\n*   **P**opulation/Participants: Who are you interested in?\n*   **I**ntervention/Exposure: What is the intervention, treatment, or exposure you are investigating?\n*   **C**omparison: What is the intervention/exposure being compared against? (e.g., placebo, usual care, another intervention, no exposure).\n*   **O**utcome: What are the effects, results, or outcomes you want to measure?\n*   **S**tudy Design (optional but highly recommended for meta-analysis): What type of studies will you include (e.g., Randomized Controlled Trials (RCTs), cohort studies, case-control studies, diagnostic accuracy studies)?\n\n### Step-by-Step Guide to Developing Your Question:\n\n#### Step 1: Identify Your Broad Area of Interest\n\nStart with a general topic you\u0027re passionate about or an area where you see a gap in existing knowledge.\n\n*   *Example:* \u0022Treatments for depression.\u0022\n*   *Example:* \u0022Risk factors for cardiovascular disease.\u0022\n*   *Example:* \u0022Diagnostic accuracy of a new test.\u0022\n\n#### Step 2: Conduct a Preliminary Literature Scan\n\nBefore you finalize your question, do a quick search in databases like PubMed or Google Scholar.\n*   Are there existing meta-analyses on this topic? If so, is there a specific nuance they missed, or can you update it with newer studies?\n*   Is there enough primary research to warrant a meta-analysis? If there are only 1-2 studies, a narrative review might be more appropriate.\n*   Are there conflicting findings in the literature that a meta-analysis could resolve?\n\n#### Step 3: Define Your PICO/PECO/PICOS Elements\n\nThis is the most crucial step. Be as specific as possible for each element.\n\n**P - Population/Participants:**\n*   **Who specifically?** (e.g., adults, children, adolescents, elderly)\n*   **What condition/disease?** (e.g., major depressive disorder, type 2 diabetes, heart failure)\n*   **Any specific characteristics?** (e.g., newly diagnosed, treatment-resistant, specific comorbidities, geographic region, socioeconomic status)\n*   *Bad:* \u0022Patients\u0022\n*   *Good:* \u0022Adults (18-65 years) diagnosed with major depressive disorder (DSM-5 criteria) who have not responded to at least one antidepressant.\u0022\n\n**I - Intervention/Exposure:**\n*   **What exact intervention?** (e.g., specific drug name and dosage, psychotherapy type, surgical procedure, lifestyle intervention)\n*   **What exact exposure?** (e.g., smoking, air pollution, specific dietary pattern)\n*   **Any specific duration or intensity?**\n*   *Bad:* \u0022Antidepressants\u0022\n*   *Good:* \u0022Cognitive Behavioral Therapy (CBT) delivered by a trained therapist for a minimum of 8 sessions.\u0022\n*   *Good (for exposure):* \u0022Long-term exposure ( \u003E 5 years) to fine particulate matter (PM2.5) above WHO guidelines.\u0022\n\n**C - Comparison:**\n*   **What is the intervention/exposure being compared against?** (This is critical for establishing an effect size).\n*   *Intervention:* Placebo, usual care, another active intervention, waiting list, no treatment.\n*   *Exposure:* Unexposed group, group with lower exposure, population average.\n*   *Diagnostic:* Gold standard test.\n*   *Bad:* \u0022Nothing\u0022\n*   *Good:* \u0022Standard pharmacological treatment (e.g., Selective Serotonin Reuptake Inhibitors - SSRIs).\u0022\n*   *Good (for exposure):* \u0022Individuals with low or no exposure to PM2.5.\u0022\n\n**O - Outcome:**\n*   **What specific, measurable outcome are you looking for?** This must be something that studies *report quantitatively*.\n*   **Primary outcome:** The most important one.\n*   **Secondary outcomes:** Other relevant effects.\n*   **How will it be measured?** (e.g., mean difference in scores, incidence rate, odds ratio, relative risk, sensitivity, specificity, mortality).\n*   *Bad:* \u0022Better health\u0022\n*   *Good:* \u0022Reduction in Hamilton Depression Rating Scale (HDRS) scores (mean difference).\u0022\n*   *Good:* \u0022Incidence of major adverse cardiovascular events (MACE) (hazard ratio).\u0022\n*   *Good (for diagnostic):* \u0022Sensitivity and specificity for detecting early-stage lung cancer.\u0022\n\n**S - Study Design (Highly Recommended):**\n*   **What types of studies will you include?** This directly impacts the strength of evidence and generalizability.\n*   *Intervention:* Randomized Controlled Trials (RCTs) are ideal for assessing causality.\n*   *Prognosis/Risk Factors:* Cohort studies, case-control studies.\n*   *Prevalence:* Cross-sectional studies.\n*   *Diagnostic Accuracy:* Studies comparing a diagnostic test to a gold standard.\n*   *Bad:* \u0022Any study\u0022\n*   *Good:* \u0022Randomized Controlled Trials (RCTs).\u0022\n*   *Good:* \u0022Prospective cohort studies.\u0022\n\n#### Step 4: Formulate Your Specific Research Question(s)\n\nNow, combine your PICO/PECO/PICOS elements into a clear, concise question.\n\n**General Template:**\n\u0022In [P], what is the effect of [I] compared to [C] on [O], as reported in [S]?\u0022\n\u0022What is the diagnostic accuracy (sensitivity and specificity) of [I] compared to [C] for [O] in [P], as reported in [S]?\u0022\n\n---\n\n### Examples of Specific Meta-Analysis Research Questions:\n\n**1. Intervention/Treatment Effect (using PICO-S):**\n\n*   **P:** Adults (aged 18-65) with moderate-to-severe major depressive disorder (MDD) resistant to at least one antidepressant.\n*   **I:** Psilocybin-assisted psychotherapy.\n*   **C:** Placebo-controlled psychotherapy or standard antidepressant treatment.\n*   **O:** Change in validated depression symptom scores (e.g., HDRS, PHQ-9) from baseline to follow-up (e.g., 4-12 weeks post-intervention).\n*   **S:** Randomized Controlled Trials (RCTs).\n\n    **Question:** \u0022In adults (aged 18-65) with moderate-to-severe major depressive disorder resistant to at least one antidepressant, what is the efficacy of psilocybin-assisted psychotherapy compared to placebo-controlled psychotherapy or standard antidepressant treatment on change in validated depression symptom scores (e.g., HDRS, PHQ-9) from baseline to follow-up (4-12 weeks post-intervention), as reported in Randomized Controlled Trials?\u0022\n\n**2. Prognosis/Risk Factor (using PECO-S):**\n\n*   **P:** Patients diagnosed with non-small cell lung cancer (NSCLC) at any stage.\n*   **E:** Presence of EGFR gene mutations.\n*   **C:** Absence of EGFR gene mutations.\n*   **O:** Overall survival (OS) and progression-free survival (PFS) (hazard ratios).\n*   **S:** Prospective or retrospective cohort studies.\n\n    **Question:** \u0022In patients diagnosed with non-small cell lung cancer (NSCLC), what is the impact of EGFR gene mutations on overall survival (OS) and progression-free survival (PFS) compared to the absence of these mutations, as reported in prospective or retrospective cohort studies?\u0022\n\n**3. Diagnostic Accuracy (using PICO-S adaptation):**\n\n*   **P:** Adult patients (aged \u003E18) presenting with suspected acute appendicitis.\n*   **I:** Ultrasound (US) examination.\n*   **C:** Surgical pathology (gold standard).\n*   **O:** Sensitivity and specificity for diagnosing acute appendicitis.\n*   **S:** Diagnostic accuracy studies.\n\n    **Question:** \u0022In adult patients presenting with suspected acute appendicitis, what is the diagnostic accuracy (sensitivity and specificity) of ultrasound (US) examination for diagnosing acute appendicitis compared to surgical pathology as the gold standard, as reported in diagnostic accuracy studies?\u0022\n\n**4. Prevalence (P, O, S adaptation - less emphasis on C):**\n\n*   **P:** Healthcare workers globally.\n*   **O:** Prevalence of burnout (measured by Maslach Burnout Inventory or similar validated tools).\n*   **S:** Cross-sectional studies.\n\n    **Question:** \u0022What is the global prevalence of burnout among healthcare workers, as reported in cross-sectional studies utilizing validated burnout assessment tools?\u0022\n\n---\n\n### Key Considerations When Developing Your Question:\n\n*   **Feasibility:** Is there enough existing literature to answer your question with a meta-analysis? (Initial scan helps here). Is it too broad (requiring thousands of studies) or too narrow (only 1-2 studies)?\n*   **Relevance:** Why is this question important? What gap in knowledge will it fill? Who benefits from knowing the answer?\n*   **Measurability:** Can the outcomes be combined statistically? Are there consistent measures across studies?\n*   **Homogeneity vs. Heterogeneity:** While you aim for similar studies, acknowledge that some variation (heterogeneity) will exist. Your question should allow for meaningful synthesis despite this.\n*   **Iterative Process:** Your initial question might need refinement as you delve deeper into the literature. It\u0027s okay to adjust it, but document all changes.\n\nOnce you have your specific research question, you\u0027re ready for the next steps in designing your meta-analysis, starting with developing a comprehensive protocol!"}' published-date="{DateTime.UtcNow:HH:mm}"
/>

## Analysis

This comparison demonstrates the different approaches each AI model takes when responding to the same prompt. Here are the key differences observed:

### Response Characteristics

**ChatGPT**: Provides a direct response with 31 sentences. 

**Gemini**: Provides a direct response with 126 sentences. 

## Key Takeaways

- Each model brings unique strengths to this type of query
- Response styles vary significantly between models
- Consider your specific use case when choosing between these models

## Try This Comparison Yourself

Want to test these models with your own prompts? Visit [SNEOS.com](https://sneos.com) to compare AI responses side-by-side in real-time.

---

*This comparison was generated using the [SNEOS AI Comparison Tool](https://sneos.com)*
*Published: October 15, 2025 | Models: ChatGPT, Gemini*
